Since Sal B accounts for 57% of total phenolic acid content when compared to about 1% for Sal A [50] and Sal B was evidently a potent ATP-competitive inhibitor of GSK-3β in the present work, it might represent the prime component from salvia that could be developed into anti-AD drugs along with other rosmarinic acid derivatives. This evidence concerns the gene GSK3B and Alzheimer disease.